GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Net Income (Discontinued Operations)
中文

Read-Gene (WAR:RDG) Net Income (Discontinued Operations) : zł0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Read-Gene Net Income (Discontinued Operations)?

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods. Read-Gene's Net Income (Discontinued Operations) for the three months ended in Sep. 2023 was zł0.00 Mil. Its Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Sep. 2023 was zł0.00 Mil.

Read-Gene Net Income (Discontinued Operations) Historical Data

The historical data trend for Read-Gene's Net Income (Discontinued Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Read-Gene Net Income (Discontinued Operations) Chart

Read-Gene Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Income (Discontinued Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Read-Gene Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Income (Discontinued Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Read-Gene Net Income (Discontinued Operations) Calculation

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods.

Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Read-Gene Net Income (Discontinued Operations) Related Terms

Thank you for viewing the detailed overview of Read-Gene's Net Income (Discontinued Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Read-Gene (WAR:RDG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Net Income (Discontinued Operations)
Comparable Companies
WAR:PUR WAR:GX1 WAR:NNG WAR:SCS WAR:PHR WAR:PFM WAR:URT OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY
Traded in Other Exchanges
N/A
Address
Ulica Alabastrowa 8, Grzepnica, Dobra, POL, 72-003
Website
http://www.read-gene.com
Read-Gene SA treats each patient individually based on genetic tests. The company's segments include chemoprevention, clinical trials and genetic tests. It also engaged in developing technologies to commercialize methods to detect, prevent and treat malignant tumours.

Read-Gene (WAR:RDG) Headlines

No Headlines